Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to -$3.9 million.

  • Regenerative Medical Technology's Non Operating Income fell 33096.67% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 4490.28%. This contributed to the annual value of -$5.6 million for FY2024, which is 3796.57% up from last year.
  • As of Q3 2025, Regenerative Medical Technology's Non Operating Income stood at -$3.9 million, which was down 33096.67% from -$1.1 million recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Non Operating Income registered a high of -$120926.0 during Q4 2023, and its lowest value of -$5.8 million during Q3 2023.
  • Over the past 5 years, Regenerative Medical Technology's median Non Operating Income value was -$1.1 million (recorded in 2022), while the average stood at -$1.6 million.
  • As far as peak fluctuations go, Regenerative Medical Technology's Non Operating Income surged by 8725.62% in 2023, and later plummeted by 74250.2% in 2024.
  • Regenerative Medical Technology's Non Operating Income (Quarter) stood at -$2.5 million in 2021, then soared by 61.94% to -$948900.0 in 2022, then soared by 87.26% to -$120926.0 in 2023, then plummeted by 742.5% to -$1.0 million in 2024, then plummeted by 283.59% to -$3.9 million in 2025.
  • Its last three reported values are -$3.9 million in Q3 2025, -$1.1 million for Q2 2025, and -$894999.0 during Q1 2025.